Connect
← Return to Innovative Peptide based eye drops for dry AMD
Discussion
Innovative Peptide based eye drops for dry AMD
Eye Conditions | Last Active: 11 hours ago | Replies (10)Comment receiving replies
investigated the use of a Fas-blocking peptide administered via eye drops. This research demonstrated that the peptide could reach the retina and mitigate degeneration by modulating inflammatory cytokines and inhibiting Fas-mediated apoptosis in animal models. The findings suggest potential therapeutic applications for dry AMD, though further studies are needed to assess its efficacy in humans.
PUBMED
Additionally, the National Science Foundation awarded a grant for the development of a synthetic peptide, ACT1, aimed at treating AMD. This research focuses on the ocular delivery of ACT1, highlighting the interest in peptide-based therapies for this condition.
NSF - NATIONAL SCIENCE FOUNDATION
These studies underscore the active pursuit of peptide-based treatments for dry AMD within the U.S. research community.
Replies to "investigated the use of a Fas-blocking peptide administered via eye drops. This research demonstrated that the..."
Connect
Peptide-based therapies for AMD are in the experimental stages, with several showing potential in preclinical and early clinical trials. However, more extensive research and clinical validation are necessary to confirm their safety and efficacy. It's advisable to consult with your healthcare providers before considering new treatments, as they can offer guidance based on the most current and comprehensive information.